We identified the most valuable differences for predicting the effect of NICT treatment, namely the density of CD8+ T cells, PD-L1+ T cells, and PD-L1+CD8+T cells within the tumor nest (rather than the stroma). The gene discussed is CD8A; the disease is neoplasm.